DR. Lynne A Bui, M.D. is a hematology and oncology internal medicine in Gilroy, CA with 27 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Lynne A Bui, M.D. NPI is 1114169323. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE
Graduation Year:1997
The provider's business location address is:
9460 N NAME UNO STE 230
GILROY, CA
ZIP 95020-538
Phone: (408) 384-9284
Fax: (408) 847-6196
The NPI 1114169323 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour (HCPCS:96367)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
The enumeration date for this NPI number is 4/2/2009 and was last updated on 8/3/2022.